Here is why Tandem Diabetes Care Inc. (TNDM) stock volatility recorded over the last month was 4.79%

Let’s start up with the current stock price of Tandem Diabetes Care Inc. (TNDM), which is $105.32 to be very precise. The Stock rose vividly during the last session to $104.58 after opening rate of $101.48 while the lowest price it went was recorded $100.10 before closing at $104.28.

Recently in News on July 30, 2020, Tandem Diabetes Care Announces Second Quarter 2020 Financial Results and Full Year 2020 Sales Guidance. Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2020. In addition, the Company provided sales guidance for the year ending December 31, 2020. You can read further details here

Tandem Diabetes Care Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $110.80 on 07/31/20, with the lowest value was $43.69 for the same time period, recorded on 03/18/20.

Tandem Diabetes Care Inc. (TNDM) full year performance was 64.40%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Tandem Diabetes Care Inc. shares are logging -3.04% during the 52-week period from high price, and 141.06% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $43.69 and $108.62.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1066011 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Tandem Diabetes Care Inc. (TNDM) recorded performance in the market was 74.94%, having the revenues showcasing 30.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 6.47B, as it employees total of 1043 workers.

Market experts do have their say about Tandem Diabetes Care Inc. (TNDM)

During the last month, 0 analysts gave the Tandem Diabetes Care Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 81.17, with a change in the price was noted +33.39. In a similar fashion, Tandem Diabetes Care Inc. posted a movement of +46.77% for the period of last 100 days, recording 1,236,301 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TNDM is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Tandem Diabetes Care Inc. (TNDM)

Raw Stochastic average of Tandem Diabetes Care Inc. in the period of last 50 days is set at 83.06%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 68.10%. In the last 20 days, the company’s Stochastic %K was 68.71% and its Stochastic %D was recorded 64.43%.

Bearing in mind the latest performance of Tandem Diabetes Care Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 74.94%. Additionally, trading for the stock in the period of the last six months notably improved by 40.86%, alongside a boost of 64.40% for the period of the last 12 months. The shares increased approximately by 0.73% in the 7-day charts and went down by 5.42% in the period of the last 30 days. Common stock shares were driven by 30.71% during last recorded quarter.